54 products were found matching your search for Insurer in 1 shops:

Investment Management for Insurers details all phases of the investment management process for insurers as well as fixed income instruments and derivatives and state-of-the-art analytical tools for valuing securities and measuring risk. Complete coverage includes: a general overview of issues, fixed income products, valuation, measuring and controlling interest rate risk, and equity portfolio management.

A talented team of authors collaborated to provide updates in new developments in sales inducements, persistency bonuses, other SOP 03-1 issues, FAS 133 interpretations (including B36, treatments for GMDB, GMAB, GMIB and GMWB), no-lapse s, EIA valuation, shock-lapse examples and totally new purchase GAAP addressing FAS141 and FAS142 and VA DAC practices. The text includes more foreign product examples, reinsurance accounting, fair value perspectives and GAAP balance sheet and income statement examples in 100 new spreadsheets and over 200 additional pages.

Investment Management for Insurers details all phases of the investment management process for insurers as well as fixed income instruments and derivatives and state-of-the-art analytical tools for valuing securities and measuring risk. Complete coverage includes: a general overview of issues, fixed income products, valuation, measuring and controlling interest rate risk, and equity portfolio management.

Solvency Requirements for EU Insurers provides a unique insights into the complex world of insurance and will be useful to risk managers, actuaries, accountants, lawyers, board members of (re) insurance companies, insurance intermediaries, consultants, regulators, supervisors, academics, students and, more generally, all those involved with or interested in insurance and in the operation of the insurance market.

A talented team of authors collaborated to provide updates in new developments in sales inducements, persistency bonuses, other SOP 03-1 issues, FAS 133 interpretations (including B36, treatments for GMDB, GMAB, GMIB and GMWB), no-lapse s, EIA valuation, shock-lapse examples and totally new purchase GAAP addressing FAS141 and FAS142 and VA DAC practices. The text includes more foreign product examples, reinsurance accounting, fair value perspectives and GAAP balance sheet and income statement examples in 100 new spreadsheets and over 200 additional pages.

Solvency Requirements for EU Insurers provides a unique insights into the complex world of insurance and will be useful to risk managers, actuaries, accountants, lawyers, board members of (re) insurance companies, insurance intermediaries, consultants, regulators, supervisors, academics, students and, more generally, all those involved with or interested in insurance and in the operation of the insurance market.

In the modern Western world, we tend to be insured by the state or for-profit insurers. We have privileged this system over mutual or micro-insurance, whose long and rich history we tend to forget. Yet, mutual and micro-insurance is becoming increasingly important, both in the Western and in the non-Western world and bears re-examination. This book traces the track record of mutual insurance from 1550 to the present, examining provisions for burial, sickness, unemployment, old age, and widowhood. The author seeks to address such topics as the type of risks micro-insurance covered between 1550 and 2015; how it was organized throughout its history; who provided the coverage; and how contributions, benefit levels, and conditions have changed. Importantly, the author explores why this system has worked through, and endured, the test of time. Mutual insurance can, for instance, overcome classic insurance problems such as adverse selection and moral hazards. The author demonstrates that the study of the position micro-insurance historically assumed in mixed economies of welfare presents interesting lessons for today’s insurance market, as well as for today’s mutualism.

A hard-hitting critique of how managed care and the selective use of science to privilege quick-fix therapies have undermined in-depth psychotherapy—to the detriment of patients and practitionersIn recent decades there has been a decline in the quality and availability of psychotherapy in America that has gone largely unnoticed—even though rates of anxiety, depression, and suicide are on the rise. In Saving Talk Therapy, master therapist Dr. Enrico Gnaulati presents powerful case studies from his practice to remind patients and therapists alike how and why traditional talk therapy works and, using cutting-edge research findings, unpacks the problematic incentives in our health-care system and in academic psychology that explain its decline.Beginning with a discussion of the historical development of talk therapy, Dr. Gnaulati goes on to dissect the factors that have undermined it. Psychotropic drugs, if no longer thought of as a magical cure, are still over-prescribed and shunt health-care dollars to drug corporations. Managed-care companies and mental health “carve outs” send health-care dollars to administrators, drive many practitioners away, and over-burden those who remain. And drawing back the curtains on CBT (cognitive behavior therapy), Dr. Gnaulati shows that while it might be effective in the research lab, its findings are of limited use for the people’s complex, real-world emotional problems.Saving Talk Therapy is a passionate and deeply researched case for in-depth, personally transformative psychotherapy that incorporates the benefits of an evidence-based approach and psychotropic drugs without over-relying on them.

A hard-hitting critique of how managed care and the selective use of science to privilege quick-fix therapies have undermined in-depth psychotherapy—to the detriment of patients and practitionersIn recent decades there has been a decline in the quality and availability of psychotherapy in America that has gone largely unnoticed—even though rates of anxiety, depression, and suicide are on the rise. In Saving Talk Therapy, master therapist Dr. Enrico Gnaulati presents powerful case studies from his practice to remind patients and therapists alike how and why traditional talk therapy works and, using cutting-edge research findings, unpacks the problematic incentives in our health-care system and in academic psychology that explain its decline.Beginning with a discussion of the historical development of talk therapy, Dr. Gnaulati goes on to dissect the factors that have undermined it. Psychotropic drugs, if no longer thought of as a magical cure, are still over-prescribed and shunt health-care dollars to drug corporations. Managed-care companies and mental health “carve outs” send health-care dollars to administrators, drive many practitioners away, and over-burden those who remain. And drawing back the curtains on CBT (cognitive behavior therapy), Dr. Gnaulati shows that while it might be effective in the research lab, its findings are of limited use for the people’s complex, real-world emotional problems.Saving Talk Therapy is a passionate and deeply researched case for in-depth, personally transformative psychotherapy that incorporates the benefits of an evidence-based approach and psychotropic drugs without over-relying on them.

Supported throughout by testimonies and interviews of prominent physicians and scientists concerned about disease-mongering, it takes an in-depth look at medical professionals who have a stake in keeping their patients convinced that they are, or are in immediate danger of becoming, sick. Examines each of the factors which have contributed to this insidious phenomenon—from an increase in the number of doctors and their specializations to the role of insurance companies. Details how to avoid disease-mongering professionals and how to keep your physician honest when dealing with you. Packed with case studies and anecdotes.

May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 0.45

In the modern Western world, we tend to be insured by the state or for-profit insurers. We have privileged this system over mutual or micro-insurance, whose long and rich history we tend to forget. Yet, mutual and micro-insurance is becoming increasingly important, both in the Western and in the non-Western world and bears re-examination. This book traces the track record of mutual insurance from 1550 to the present, examining provisions for burial, sickness, unemployment, old age, and widowhood. The author seeks to address such topics as the type of risks micro-insurance covered between 1550 and 2015; how it was organized throughout its history; who provided the coverage; and how contributions, benefit levels, and conditions have changed. Importantly, the author explores why this system has worked through, and endured, the test of time. Mutual insurance can, for instance, overcome classic insurance problems such as adverse selection and moral hazards. The author demonstrates that the study of the position micro-insurance historically assumed in mixed economies of welfare presents interesting lessons for today’s insurance market, as well as for today’s mutualism.

Mutually Beneficial tells the story of the evolution of The Guardian Life Insurance Company of America, one of the most important life and health insurers in the history of the U.S. economy and life insurance industry. Relying on exclusive access to the company's archives, interviews with its current executive officers, the public record, and scholarly articles and monographs, Robert E. Wright and George David Smith provide a strategic analysis of Guardian, from its founding to its standing in the insurance world today. Mutually Beneficial also describes the origin of Guardian's distinctive approach to business—its corporate culture and policy—and how these principles flow from the ethical and business precepts of its founders. By rigorously attending to its policyholders as a matter of practice as well as principle, Guardian has long been one of the most consistently profitable life insurance firms as measured by return on net wealth. This unique history will be of interest to anyone in the insurance business, as well as financial and economic professionals.

Medicaid is the single largest public health insurer in the United States, covering upwards of 70 million Americans. Crucially, Medicaid is also an intergovernmental program that yokes poverty to federalism: the federal government determines its broad contours, while states have tremendous discretion over how Medicaid is designed and implemented. Where some locales are generous and open handed, others are tight-fisted and punitive. In Fragmented Democracy, Jamila Michener demonstrates the consequences of such disparities for democratic citizenship. Unpacking how federalism transforms Medicaid beneficiaries' interpretations of government and structures their participation in politics, the book examines American democracy from the vantage point(s) of those who are living in or near poverty, (disproportionately) Black or Latino, and reliant on a federated government for vital resources.

Most academic and policy commentary represents adverse selection as a severe problem in insurance, which should always be deprecated, avoided or minimised. This book gives a contrary view. It details the exaggeration of adverse selection in insurers' rhetoric and insurance economics, and presents evidence that in many insurance markets, adverse selection is weaker than most commentators suggest. A novel arithmetical argument shows that from a public policy perspective, 'weak' adverse selection can be a good thing. This is because a degree of adverse selection is needed to maximise 'loss coverage', the expected fraction of the population's losses which is compensated by insurance. This book will be valuable for those interested in public policy arguments about insurance and discrimination: academics (in economics, law and social policy), policymakers, actuaries, underwriters, disability activists, geneticists and other medical professionals.

This comprehensive book thoroughly addresses every aspect of Independent Medical Evaluations, an important part of many medical specialty disciplines where forensic opinions are needed by patients, physicians, insurers, and attorneys. Independent Medical Evaluation: A Practical Guide begins by defining the IME product and the IME evaluator themselves, explaining the medicolegal systems, and providing guidance towards establishing these professional services. Following this, the book describes how to best use medical records, and best-practices for taking an IME history and conducting an examination. The final few chapters cover developing an IME report, the common challenges and pitfalls encountered, with strategies and pearls shared to illustrate how to avoid them. Structured in a concise, practical format, this essential guide includes a large selection of sample models and templates, for additional teaching purposes.The first of its kind, Independent Medical Evaluation: A Practical Guide is a unique and ideal reference text for any physician working with IME’s, from the physician conducting their first exam, to the experienced physician alike.

Decisions made by physicians, patients, health policy makers and health insurers determine the quality of health care that is needed and provided for. This up-to-date, comprehensive overview of medical decision making reveals a rapidly expanding field. The book covers quantitative theoretical tools for modeling decisions, psychological research on how decisions are actually made, and applied research on how physician and patient decision making can be improved. Hb ISBN (2000): 0-521-64159-4

This superb volume features medals of bravery awarded to seaman in the Merchant Navy during World War II, of the estimated 145,000 seaman who served between 1939-1945, approx 40,000 valient men and women lost their lives, Lloyd's the worlds largest insurer of ships struck medals to award those whose heroic deeds were noted, The awards are listed with a brief account of circumstances, excellent referrence volume. SIGNED BY THE AUTHOR on the title page

A new book co-written by Stephen Catlin, the founder and former CEO of international insurer Catlin Group Limited and a member of the Insurance Hall of Fame, provides unique insights into the inner workings of the commercial property/casualty insurance industry. In 'Risk & Reward', co-written with James Burcke, Stephen Catlin draws on his more than 40 years of experience as an underwriter and insurance company executive to discuss some of the more important practices and concepts underlying the insurance business. 'Risk & Reward' includes Stephen's candid views regarding basic insurance industry practices and how they could be improved; the major challenges facing insurers today, including the growth of cyber exposures and the industry's failure to address critical problems relating to processing, data and transactional costs; and key management principles, including leadership, talent management, brand-building and the need to develop a cohesive corporate culture. Risk & Reward also traces Stephen's entrepreneurial journey in transforming Catlin Group Limited from a tiny Lloyd's of London underwriting agency to a global insurer that underwrote $6 billion in annual premium volume when it was acquired in 2015. Individuals who work in the insurance industry - and even those who know little about insurance - will benefit from Stephen Catlin's wisdom and insights.

Written by insurers for insurers, The Solvency II Handbook: Practical Approaches to Implementation is a hugely important text for all practitioners in the field, as well as consultants and students. Focusing on implementation and the challenges, it'll help you to solve practical problems in your day to day job saving you time and costly mistakes. As the title suggests this book focuses on the practical side of Solvency II and the actual implementation. The original best-selling Solvency II Handbook, published by Risk Books in 2009, focused on the theory with a detailed examination of the main requirements and impacts of Solvency II to insurers and reinsurers. Both books complement each other and should be read by anyone dealing with Solvency II in any capacity. Search for the Solvency II Handbook by Marcelo Cruz in Amazon for more information. Solvency II is being implemented in 2016. Larger companies are making progress but are still interested in hearing each other s stories. Smaller companies who started later are now in the phase of finalising their Solvency II projects. Now is the time when they will need to resolve any issues that arise; this book provides answers to their questions. Edited by best-selling author René Doff, this book focuses on the implementation and challenges of Solvency II. Including many case studies from insurers, you will gain a very interesting and useful snapshot of Solvency II implementation. Organised around the three pillars of Solvency II, topics covered include: - Internal models and Solvency II - Managing model risk - Solvency II and reinsurance - ORSA: A forward-looking approach to risk and capital management - Reporting challenges under Solvency II - The holistic balance sheet - Capital for operational risk